June 2, 2025 — The FDA has approved Moderna’s new COVID-19 shot, an mRNA vaccine, with some limits on who can get it. The vaccine, called mNexspike, is for people who’ve previously received a COVID-19… Read more
July 8, 2025 – The FDA has approved the first-ever pill to stop attacks of a rare genetic swelling disorder while they’re happening. The drug, known as sebetralstat but sold as Ekterly, is for adults… Read more
May 30, 2025 – The FDA has approved the first-ever meningococcal vaccine for babies as young as 6 weeks old. Sanofi Pasteur’s quadrivalent MenQuadfi shot was first cleared in 2020 for adults and children ages 2… Read more
July 7, 2025 – The FDA has granted quick approval to a first-of-its-kind pill for a type of lung cancer known as non-small-cell lung cancer (NSCLC). The drug, called sunvozertinib and sold as Zegfrovy, is… Read more
May 19, 2025 – The FDA has approved the Novavax COVID-19 vaccine, a protein-based alternative to mRNA shots, with some limits on who can get it. The vaccine, called Nuvaxovid, is mainly intended for adults 65… Read more
May 2, 2025 — The FDA has approved a new treatment for generalized myasthenia gravis (gMG), a disease that causes severe muscle weakness, faster muscle fatigue, and difficulty in speaking and swallowing. It offers long-lasting option… Read more
May 30, 2025 — The FDA has approved a new treatment for dry eye disease (DED) after studies showed it can help stimulate natural tear production as early as the first day of use. The new… Read more
Inlexzo is a new treatment for a type of bladder cancer in adults that hasn’t spread to the muscles and doesn’t respond to Bacillus Calmette-Guérin (BCG) therapy. It’s approved for treating non-muscle invasive bladder cancer… Read more
Vonvendi is a lab-made version of von Willebrand factor (VWF), a protein your body needs for blood to clot. Affecting more than 3 million people in the U.S, von Willebrand disease (VWD) is a common… Read more
Tremfya (guselkumab) is a lab-made, dual-acting antibody medication that reduces inflammation by targeting the interleukin-23 (IL-23) protein and blocking a majority of the cells that produce it. It is available by prescription. The FDA has… Read more